U.S. markets open in 1 hour 44 minutes
  • S&P Futures

    4,004.75
    -15.00 (-0.37%)
     
  • Dow Futures

    32,060.00
    -60.00 (-0.19%)
     
  • Nasdaq Futures

    12,317.25
    -65.50 (-0.53%)
     
  • Russell 2000 Futures

    1,781.50
    -8.00 (-0.45%)
     
  • Crude Oil

    109.02
    -1.47 (-1.33%)
     
  • Gold

    1,798.70
    -9.50 (-0.53%)
     
  • Silver

    21.09
    +0.09 (+0.45%)
     
  • EUR/USD

    1.0429
    +0.0012 (+0.11%)
     
  • 10-Yr Bond

    2.9350
    0.0000 (0.00%)
     
  • Vix

    29.43
    -2.34 (-7.37%)
     
  • GBP/USD

    1.2255
    -0.0007 (-0.06%)
     
  • USD/JPY

    129.4670
    +0.2820 (+0.22%)
     
  • BTC-USD

    30,024.25
    -105.20 (-0.35%)
     
  • CMC Crypto 200

    672.68
    -8.43 (-1.24%)
     
  • FTSE 100

    7,415.98
    -2.17 (-0.03%)
     
  • Nikkei 225

    26,547.05
    +119.40 (+0.45%)
     

Centrus Energy Benefits From Roth Capital Upgrade

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

By Sam Boughedda

Investing.com — Nuclear fuel company Centrus Energy (NYSE:LEU) has been one of the more significant movers Tuesday after receiving a boost from Roth Capital analysts.

Roth Capital upgraded the stock to buy from hold, raising its price target to $58, up only from $57, to "reflect the impact from the completion of the Preferred Stock redemption," which is a "small benefit to the valuation," analyst Joe Reagor told investors in a research note.

The analyst added that since he last wrote about the company, its share price has declined significantly, reflecting a reversal of non-fundamental trading in Centrus shares, while he is also expecting operating results to improve next year.

On Nov. 12, Centrus Energy's shares hit an intraday high of $88.88, but since then, they have experienced an almost constant decline, touching a low of just under $44 last Wednesday. However, following today's note from Roth, Centrus' stock is up 16%.

"Given the company's current share price of $47.06 and our outlook for improved operating results in 2022, we are returning to a Buy rating," explained Reagor.

Related Articles

Centrus Energy Benefits From Roth Capital Upgrade

Musk's SpaceX hit by 132 COVID-19 cases

Embraer shares soar on announcement of Eve deal with SPAC, NYSE listing